EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma

Kuo-Chen Hung, Kun-Lin Yang, Guan-Cheng Huang, Yu-Fu Chen, Wen-Teng Chang, Chia-Chang Chuang iD

Pleura and Peritoneum · 26.05.2020 · 5 (2)

DOI: 10.1515/pp-2019-0030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pleura and Peritoneum, online erschienen am 15.05.2020. Verfasst von Kuo-Chen Hung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University and College of Medicine, Kaohsiung 83301, Taiwan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An effective treatment strategy for peritoneal metastasis (PM) of hepatocellular carcinoma (HCC-PM) has yet to be established. Although cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have shown favorable outcomes in certain malignancies, their role in peritoneal metastatic HCC is unclear. Herein, we present a series of patients with HCC-PM treated with CRS/HIPEC and evaluate their outcomes.

Methods

Records of patients with HCC-PM who had undergone CRS/HIPEC at the Hyperthermia Center of Yuan’s General Hospital, Kaohsiung, Taiwan, between September 2015 and December 2016 were reviewed retrospectively. Patients were followed up until September 2019. We assessed the clinical courses and outcomes of these patients to clarify the benefits of CRS/HIPEC.

Results

Six patients were included in our study. HCC-PM occurred synchronously in one patient and occurred metachronously in five patients after therapeutic minimally invasive procedures, including radiofrequency ablation, laparoscopic hepatectomy, robotic hepatectomy or spontaneously. The median peritoneal cancer index was 18.5. All patients experienced complete peritoneal cytoreduction without perioperative mortality. One patient had two CTCAE grade 3 complications. The median follow-up was 16 months. The median overall survival was 15.7 months. Four patients died of lung metastasis or liver failure owing to intrahepatic recurrence. The survival rates observed at 1, 2, and 4 years were 66.7%, 33.3%, and 33.3%, respectively.

Conclusions

CRS followed by HIPEC is feasible in patients with HCC-PM and might provide selected patients a chance for local disease control and longer survival. CRS/HIPEC might be considered as a treatment option in highly selected patients, as part of multimodal therapy approaches.

Schlagwörter

Stichwörter der Autor:innen

cytoreduction surgeryhepatocellular carcinomahyperthermic intraperitoneal chemotherapyperitoneal metastasis

Autor:innen und Institutionen

  • Department of Trauma Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University and College of Medicine, Kaohsiung 83301, Taiwan.
  • Hyperthermic Center, Department of Surgery, Yuan's General Hospital, Kaohsiung 802793, Taiwan.
  • Department of Animal Science, National Peimen Agriculture and Industrial school, Tainan, Taiwan.
  • Division of Hemato-oncology, Department of Internal Medicine, Yuan's General Hospital, Kaohsiung, Taiwan.
  • Department of Education and Research, Yuan's General Hospital, Kaohsiung, Taiwan.
  • Department of Biological Science and Technology, Chung Hwa University of Medical Technology, Tainan, Taiwan.

ORCID-Profile: Chia-Chang Chuang

Zitieren

APA

Hung, K. C., Yang, K. L., Huang, G. C., Chen, Y. F., Chang, W. T., & Chuang, C. C. (2020). Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma. Pleura and Peritoneum, 5(2). https://doi.org/10.1515/pp-2019-0030

Vancouver

Hung KC, Yang KL, Huang GC, Chen YF, Chang WT, Chuang CC. Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma. Pleura and Peritoneum. 2020;5(2). doi:10.1515/pp-2019-0030

BibTeX
@article{Hung2020,
  author = {Hung, Kuo-Chen and Yang, Kun-Lin and Huang, Guan-Cheng and Chen, Yu-Fu and Chang, Wen-Teng and Chuang, Chia-Chang},
  title = {Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma},
  journal = {Pleura and Peritoneum},
  year = {2020},
  volume = {5},
  number = {2},
  doi = {10.1515/pp-2019-0030}
}
Kostenlos starten →